Valeritas, Inc.

Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese

BRIDGEWATER, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,wearable insulin delivery option for patients with diabetes, announced today a poster titled “Relationship between Baseline BMI and Clinical Outcomes with V-Go® Wearable Insulin Delivery Device in...

Read More »
Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy
Health, Medical, & Dental Supplies and Equipment

Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy

BRIDGEWATER, N.J., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today V-Go has launched and is now available in Italy through its previously disclosed exclusive distribution agreement with...

Read More »
Material Handling & Storage

Persistent Use of Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates Significant Clinical & Economic Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes

BRIDGEWATER, N.J., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today the publication this week of a manuscript titled “Clinical and Economic Considerations Based on Persistency with a...

Read More »
Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes

BRIDGEWATER, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today the publication last week of a manuscript...

Read More »
Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets
Health, Medical, & Dental Supplies and Equipment

Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets

BRIDGEWATER, N.J., April 30, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, last week presented positive findings from a new study during the poster...

Read More »
Health, Medical, & Dental Supplies and Equipment

Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™

BRIDGEWATER, N.J., April 20, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it has entered into an agreement...

Read More »
Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm
Health, Medical, & Dental Supplies and Equipment

Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm

BRIDGEWATER, N.J., Feb. 15, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it presented positive findings from its...

Read More »
V-Go Wearable Insulin Delivery Device features a cartridge made from TOPAS® COC.
Health, Medical, & Dental Supplies and Equipment

V-Go Wearable Insulin Delivery Device features a cartridge made from TOPAS® COC.

The V-Go Wearable Insulin Delivery device from Valeritas Holdings, Inc. offers patients with Type 2 diabetes an option to eliminate the need for taking multiple daily shots. The device is worn like a patch and features an injection molded cartridge of TOPAS cyclic olefin copolymer. The wearable basal is small and lightweight, and also intended to be worn under clothing. The V-Go device is fully...

Read More »
Valeritas Announces its V-Go® Wearable Insulin Delivery Device is Now Available in Puerto Rico
Health, Medical, & Dental Supplies and Equipment

Valeritas Announces its V-Go® Wearable Insulin Delivery Device is Now Available in Puerto Rico

BRIDGEWATER, N.J., Jan. 17, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today that its V-Go® Wearable Insulin Delivery device is...

Read More »
Company News

Valeritas Signs Exclusive Middle East Distribution Agreement with Julphar

- V-Go distribution deals now span 14 countries and territories -  BRIDGEWATER, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company, has signed an exclusive distribution agreement with Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, for the commercialization of its V-Go Wearable Insulin Delivery...

Read More »
Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical and Economic Benefits Across Established BMI Strata in Patients with Type 2 Diabetes Including Those Overweight and Obese

BRIDGEWATER, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,wearable insulin delivery option for patients with diabetes, announced today a poster titled “Relationship between Baseline BMI and Clinical Outcomes with V-Go® Wearable Insulin Delivery Device in...

Read More »
Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy
Health, Medical, & Dental Supplies and Equipment

Valeritas Announces That V-Go® Insulin Delivery Device Has Launched in Italy

BRIDGEWATER, N.J., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today V-Go has launched and is now available in Italy through its previously disclosed exclusive distribution agreement with...

Read More »
Company News

Valeritas Wins Fifth Consecutive Cardinal Health Supply Chain Excellence Award

BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today it has been awarded a Cardinal Health Supply Chain Excellence Award for the fifth consecutive year. “Receiving the...

Read More »
Material Handling & Storage

Persistent Use of Valeritas' V-Go® Wearable Insulin Delivery Device Demonstrates Significant Clinical & Economic Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes

BRIDGEWATER, N.J., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today the publication this week of a manuscript titled “Clinical and Economic Considerations Based on Persistency with a...

Read More »
Company News

Valeritas Announces that V-Go® Insulin Delivery Device has Launched in Australia

BRIDGEWATER, N.J., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch for patients with diabetes, today announced V-Go has launched and is now available in Australia through its previously disclosed...

Read More »
Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes
Health, Medical, & Dental Supplies and Equipment

Valeritas' V-Go® Wearable Insulin Delivery Device Results in Clinical Benefits Sustained Over Time in Patients with Diabetes

BRIDGEWATER, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today the publication last week of a manuscript...

Read More »
Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets
Health, Medical, & Dental Supplies and Equipment

Valeritas Presented New Data Demonstrating use of V-Go® Wearable Insulin Delivery Device Results in More Patients with Type 2 Diabetes Achieving Blood Glucose Targets

BRIDGEWATER, N.J., April 30, 2018 - Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, last week presented positive findings from a new study during the poster...

Read More »
Health, Medical, & Dental Supplies and Equipment

Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™

BRIDGEWATER, N.J., April 20, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, announced today it has entered into an agreement...

Read More »

All Topics